Cornovus Pharmaceuticals Inc. — Form D
Cornovus Pharmaceuticals Inc. of FARMINGTON, CT, a company, filed a Form D exempt-offering notice with the SEC on 2014-03-03. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Other.
Offering
- Filed: 2014-03-03
- Form: D
- Accession: 0001600112-14-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Minimum investment: $1.6M
- Investors: 1
- Date of first sale: 2014-02-28
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-212774
Issuer
- Name: Cornovus Pharmaceuticals Inc.
- CIK: 0001600112
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 400 FARMINGTON AVENUE, FARMINGTON, CT, 06032
- Phone: 860-679-7894
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Robert Mark Van Allen | Executive Officer | New Haven, CT |
| Daniel Wagner | Director | Branford, CT |
| Timothy Shannon | Director | Stamford, CT |
| R. Mark Van Allen | Executive Officer | Farmington, CT |
| Glenn Mattes | Director | San Marcos, CA |
| Glenn Mattes | Executive Officer | San Marcos, CA |
| Bruce Liang | Director | Avon, CT |
| Raymond Neag | Director | Wyomissing, PA |
Other filings by this issuer (2)
More